Drug repurposing for COVID-19: A review and a novel strategy to identify new targets and potential drug candidates

L Rodrigues, R Bento Cunha, T Vassilevskaia… - Molecules, 2022 - mdpi.com
In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the …

Standards of care for the health of transgender and gender diverse people, version 8

E Coleman, AE Radix, WP Bouman… - … journal of transgender …, 2022 - Taylor & Francis
Background: Transgender healthcare is a rapidly evolving interdisciplinary field. In the last
decade, there has been an unprecedented increase in the number and visibility of …

Management of endocrine disease: Optimal feminizing hormone treatment in transgender people

D Glintborg, G T'Sjoen, P Ravn… - European journal of …, 2021 - academic.oup.com
Transgender women are assigned male at birth but identified as women. The incidence of
gender dysphoria is estimated to be around 1% of the population. Gender dysphoria may be …

The impact of gender-affirming hormone therapy on physical performance

AS Cheung, S Zwickl, K Miller, BJ Nolan… - The Journal of …, 2024 - academic.oup.com
Context The inclusion of transgender people in elite sport has been a topic of debate. This
narrative review examines the impact of gender-affirming hormone therapy (GAHT) on …

Toward a lowest effective dose of cyproterone acetate in trans women: results from the ENIGI study

SME Kuijpers, CM Wiepjes… - The Journal of …, 2021 - academic.oup.com
Context Cyproterone acetate (CPA) is a competitive inhibitor of the androgen receptor and
exerts negative hypothalamic feedback. It is often used in combination with estrogens in …

Sex and gender differences in clinical pharmacology: implications for transgender medicine

LR Cirrincione, KJ Huang - Clinical Pharmacology & …, 2021 - Wiley Online Library
The transgender adult population is growing globally, but clinical pharmacology has lagged
behind other areas of transgender medicine. Medical care for transgender adults may …

SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people

AD Fisher, G Senofonte, C Cocchetti, G Guercio… - Journal of …, 2022 - Springer
Abstract Purpose Gender Incongruence (GI) is a marked and persistent incongruence
between an individual's experienced and the assigned gender at birth. In the recent years …

Transgender health and the impact of aging and menopause

AS Cheung, BJ Nolan, S Zwickl - Climacteric, 2023 - Taylor & Francis
Gender affirming hormone therapy (GAHT) is used by many transgender people to reduce
gender incongruence and improve psychological functioning. As GAHT shares many …

Sex differences in athletic performance: perspectives on transgender athletes

NJ Nokoff, J Senefeld, C Krausz… - Exercise and sport …, 2023 - journals.lww.com
Sex hormone concentrations, particularly testosterone, are primary determinants of sex-
based differences in athletic and sports performance, and this relationship may inform fair …

[HTML][HTML] Guía clínica de atención a menores transexuales, transgéneros y de género diverso

A Moral-Martos, J Guerrero-Fernández, MG Balaguer… - Anales de …, 2022 - Elsevier
Algunas personas, también las menores de edad, tienen una identidad de género que no
se corresponde con el sexo asignado al nacer. Se les conoce como personas trans*, que es …